This section will explain what causes low potassium, why it matters for patients on semaglutide, and what you can do to prevent and treat it
Additionally, it was shown that these NPs prevented cancer cells from expressing endothelial growth factor (VEGF), which reduced metastasis (126)
Large-scale, prospective trials are needed to confirm its long-term safety and efficacy
Contact your provider promptly if you have: Persistent vomiting or inability to keep fluids down Severe or worsening abdominal pain Signs of dehydration (dizziness, very dark urine, fainting, rapid heartbeat) Severe constipation lasting multiple days with significant pain Symptoms that interfere with daily function or do not improve after supportive changes Discuss dose and timing adjustments If side effects are strong after a dose increase, your clinician may consider slowing the titration, changing supportive strategies, or reviewing nutrition and hydration
The time before your first dose matters Starting a GLP-1 changes things physically and logistically
Acute liver failure: redefining the syndromes